PILERI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 7.261
AS - Asia 7.034
EU - Europa 3.944
AF - Africa 429
Continente sconosciuto - Info sul continente non disponibili 395
SA - Sud America 381
OC - Oceania 20
Totale 19.464
Nazione #
US - Stati Uniti d'America 7.051
VN - Vietnam 2.222
SG - Singapore 1.740
CN - Cina 1.529
IT - Italia 927
GB - Regno Unito 750
HK - Hong Kong 550
DE - Germania 488
SE - Svezia 481
IN - India 289
FR - Francia 257
BR - Brasile 251
RU - Federazione Russa 204
ZA - Sudafrica 179
KR - Corea 155
BD - Bangladesh 137
IE - Irlanda 136
UA - Ucraina 129
NL - Olanda 124
CA - Canada 99
CI - Costa d'Avorio 94
JP - Giappone 94
FI - Finlandia 77
BG - Bulgaria 72
CH - Svizzera 54
TG - Togo 54
EE - Estonia 52
AR - Argentina 50
MX - Messico 44
PH - Filippine 44
ID - Indonesia 42
AT - Austria 34
TR - Turchia 33
PL - Polonia 32
SC - Seychelles 30
ES - Italia 28
TH - Thailandia 28
JO - Giordania 27
NG - Nigeria 26
CO - Colombia 23
EC - Ecuador 20
AU - Australia 19
IR - Iran 18
TW - Taiwan 18
SA - Arabia Saudita 17
IQ - Iraq 15
UZ - Uzbekistan 15
CL - Cile 13
CR - Costa Rica 13
BE - Belgio 12
EG - Egitto 12
HR - Croazia 12
JM - Giamaica 12
LT - Lituania 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
HN - Honduras 8
DK - Danimarca 7
HU - Ungheria 7
LB - Libano 7
CZ - Repubblica Ceca 6
GT - Guatemala 6
PT - Portogallo 6
RO - Romania 6
RS - Serbia 6
TN - Tunisia 6
UY - Uruguay 6
GR - Grecia 5
IL - Israele 5
MD - Moldavia 5
MY - Malesia 5
NI - Nicaragua 5
PY - Paraguay 5
DZ - Algeria 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
AG - Antigua e Barbuda 2
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
CG - Congo 2
GP - Guadalupe 2
KE - Kenya 2
MK - Macedonia 2
MM - Myanmar 2
MU - Mauritius 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
Totale 19.044
Città #
Singapore 1.181
Ashburn 655
Southend 619
San Jose 592
Ho Chi Minh City 554
Fairfield 548
Hong Kong 517
Hanoi 458
Chandler 450
Hefei 325
Santa Clara 309
Council Bluffs 235
Beijing 229
Houston 226
Wilmington 220
Woodbridge 220
Seattle 218
Princeton 191
Bologna 174
Cambridge 158
Boardman 149
Dong Ket 140
Dublin 134
Seoul 134
Los Angeles 129
New York 128
Johannesburg 115
Ann Arbor 102
Abidjan 94
Lauterbourg 94
Dallas 92
Tokyo 76
Da Nang 73
Haiphong 67
Nanjing 65
Sofia 65
Westminster 65
Jacksonville 63
Milan 60
Redmond 56
Chicago 55
Helsinki 55
Berlin 54
Lomé 54
Rome 51
Buffalo 50
Redondo Beach 50
Padova 43
Saint Petersburg 41
San Diego 40
Bremen 39
Frankfurt am Main 39
Jinan 39
São Paulo 37
London 36
Phoenix 34
Turin 34
Munich 32
Redwood City 30
Shenyang 30
Bengaluru 28
Thái Nguyên 28
Amman 27
Can Tho 27
Changsha 27
Quận Bình Thạnh 27
Vienna 27
Abeokuta 25
Bern 25
Tianjin 25
Hải Dương 24
Ha Long 23
Shanghai 23
Warsaw 23
Atlanta 22
Biên Hòa 22
Florence 22
Hangzhou 22
Hebei 22
Jakarta 22
Zhengzhou 22
Guangzhou 21
Nanchang 21
San Francisco 21
Vũng Tàu 21
Bangkok 19
Falls Church 19
Montreal 19
Brooklyn 18
Des Moines 18
Delhi 17
Mexico City 17
Mülheim 17
Naples 17
Nuremberg 17
Bắc Ninh 16
Norwalk 16
Orem 16
Quận Sáu 16
Toronto 16
Totale 11.678
Nome #
Merkel cell carcinoma: a prompt diagnosis to increase survival 669
Napkin psoriasis and the risk of later psoriasis development: A single-centre retrospective study 375
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 292
Management of malignant cutaneous wounds in oncologic patients 271
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine 261
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 249
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 243
Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysis 242
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 232
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 232
Herpes zoster in COVID-19-positive patients 219
Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features. 215
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 208
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 203
Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). 193
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 191
Atopic Dermatitis and the Atopic March: What Is New? 191
Anaplastic Large Cell Lymphoma: a critical reappraisal 190
Photodynamic therapy: An option in mycosis fungoides 190
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 189
Chilblain lupus erythematosus in a patient affected by Hodgkin lymphoma 187
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 183
Mycosis fungoides following pityriasis lichenoides: An exceptional event or a potential evolution? 182
Annular lesions located on the right forearm. 180
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 178
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 177
Atypical piloleiomyoma of the face presenting with central ulceration 177
Cutaneous adverse-events in patients treated with Ibrutinib 176
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 173
Leukemia cutis in a Ph+ ALL patient treated with ponatinib 172
Chilblain lesions after COVID-19 mRNA vaccine 172
Granulomatous tattoo reaction in a nivolumab-treated patient 171
Rosacea-like tinea incognito 170
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 169
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 166
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 165
Large granular lymphocytic leukaemia mimicking ulcer of the lower limb 163
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 163
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 163
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 163
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region 160
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 160
Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine. 159
Vemurafenib mucosal side-effect. 159
Bosentan and Extracorporeal Photochemotherapy in Eosinophilic Fasciitis: Synergistic Action or Fortuitous Coincidence? 159
Persistent agmination of lymphomatoid papulosis: an ongoing debate. 156
Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopy 152
An asymptomatic plaque on the chest: A quiz 152
Papular mycosis fungoides: a new casa expanding the spectrum of phenotypic and clinical findings 151
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 151
Alopecia areata-like mycosis fungoides: Lions for lambs 151
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 150
Nb‐UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single‐center cross‐sectional study 149
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 147
Brownish asymptomatic lesions on the arms and legs 146
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 146
The best teaching ulcer? The one we cannot label—addressing data scarcity through synthetic imaging 145
The karma of Kikuchi's disease. 145
Dermatofibrosarcoma protuberans secondary to a decorative tattoo: An Isotattootopic Response? 144
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 142
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 142
Erythematous induration of the chest 141
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 141
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model 140
Epcoritamab injection site skin eruption: a frequent yet unharmful effect due to a local delayed reaction mechanism 139
A large mass and erythematous-violaceous plaques - Ein großer tumor und livid-erythematöse plaques 139
TOX Expression in Mycosis Fungoides and Sezary Syndrome 137
Peripheral T-cell lymphoma. 136
Multiple familial trichodiscomas. 136
Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace 135
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome? 135
Extramedullary metastatic plasmacytoma in a multiple myeloma patient 134
Squamous cell carcinoma developed after ingenol mebutate therapy: A possible consequence of the treatment? 134
Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients 133
Multiple Eruptive Sebaceous Hyperplasia Secondary to Muir-Torre Syndrome Treated With Fractional Carbon Dioxide Laser Resurfacing Technique: A Case Report 132
Lymphoma classification: Past, present and future 132
Indolent lymphoma: the pathologist's viewpoint 132
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis 131
New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia 129
Lymphoma classification: the quiet after the storm. 127
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma 127
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report 127
A rapidly growing ulcer: an atypical presentation of Merkel cell carcinoma 126
Cutaneous involvement in multiple myeloma. A rare entity 124
Folliculotropic mycosis fungoides of the face successfully treated combining CO2 laser and conventional photodynamic therapy (c-PDT) 123
The role of myeloid derived suppressor cells in mycosis fungoides 123
Mycosis fungoides: disease evolution of the "lion queen" revisited. 122
Pityriasis lichenoides triggered by measles-mumps-rubella vaccine injection 122
Erosive pustular dermatosis of the leg: An uncommon entity? 119
Verrucous mycosis fungoides. 117
Is Dermoscopy Useful for the Diagnosis of Pseudolymphomas? 113
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 111
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 110
Sézary Syndrome without erythroderma featuring a CD30+ progression 109
Unilesional folliculotropic mycosis fungoides: a true rarity in the clinico-pathologic spectrum? 108
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 107
Dimethyl fumarate: a case of improvement of alcoholic steatohepatitis in an elderly psoriatic patient 105
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 105
A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis 102
Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides 100
Totale 16.534
Categoria #
all - tutte 55.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.371 0 0 0 137 148 98 27 137 88 137 337 262
2022/20231.880 208 264 107 247 140 152 69 144 265 63 154 67
2023/2024593 39 109 33 48 35 109 80 44 10 36 18 32
2024/20252.752 108 363 220 213 438 103 240 100 56 176 168 567
2025/20267.664 851 1.107 583 492 728 391 629 329 1.353 573 342 286
2026/20271.404 301 294 485 324 0 0 0 0 0 0 0 0
Totale 19.464